Verde Bio Cash Per Share vs. Current Ratio

APHD Stock  USD 0.0002  0.0001  100.00%   
Considering Verde Bio's profitability and operating efficiency indicators, Verde Bio Holdings may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Verde Bio's ability to earn profits and add value for shareholders.
For Verde Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Verde Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Verde Bio Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Verde Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Verde Bio Holdings over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Verde Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verde Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verde Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Verde Bio Holdings Current Ratio vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Verde Bio's current stock value. Our valuation model uses many indicators to compare Verde Bio value to that of its competitors to determine the firm's financial worth.
Verde Bio Holdings is number one stock in cash per share category among its peers. It is rated below average in current ratio category among its peers fabricating about  0.20  of Current Ratio per Cash Per Share. The ratio of Cash Per Share to Current Ratio for Verde Bio Holdings is roughly  5.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Verde Bio's earnings, one of the primary drivers of an investment's value.

Verde Current Ratio vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Verde Bio

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.50 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Verde Bio

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
0.10 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

Verde Current Ratio Comparison

Verde Bio is currently under evaluation in current ratio category among its peers.

Verde Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Verde Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Verde Bio will eventually generate negative long term returns. The profitability progress is the general direction of Verde Bio's change in net profit over the period of time. It can combine multiple indicators of Verde Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. Apogee 21 Holdings, Inc. was founded in 2005 and is based in Wheat Ridge, Colorado. Apogee 21 operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.

Verde Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Verde Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Verde Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Verde Bio's important profitability drivers and their relationship over time.

Use Verde Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Verde Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verde Bio will appreciate offsetting losses from the drop in the long position's value.

Verde Bio Pair Trading

Verde Bio Holdings Pair Trading Analysis

The ability to find closely correlated positions to Verde Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Verde Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Verde Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Verde Bio Holdings to buy it.
The correlation of Verde Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Verde Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Verde Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Verde Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Verde Bio position

In addition to having Verde Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Equity ETFs Thematic Idea Now

Broad Equity ETFs
Broad Equity ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 483 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Verde Pink Sheet

To fully project Verde Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Verde Bio Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Verde Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Verde Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Verde Bio investors may work on each financial statement separately, they are all related. The changes in Verde Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Verde Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.